Clinical Trial: A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06898385) titled 'A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation' on March 21.

Brief Summary: This is a single-arm, open-label clinical study to evaluate the safety, tolerability and preliminary efficacy of IX001 TCR-T injection in advanced pancreatic cancer patients with KRAS G12V mutation.

Study Start Date: March 27

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer

Intervention: BIOLOGICAL: IX001 TCR-T injection

IX001 TCR-T injection will be administered intravenously after lymphodepletion.

DRUG: Fludarabine

Fludarabine is used for lymphodepletion.

D...